Rochlitz C - Search Results

1

Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification.

Guth U, Wight E, Schotzau A, Langer I, Dieterich H, Rochlitz C, Herberich L, Holzgreve W, Singer G. Guth U, et al. Among authors: rochlitz c. Cancer. 2005 Nov 1;104(9):1862-70. doi: 10.1002/cncr.21394. Cancer. 2005. PMID: 16130140 Free article.

2

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer.

Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C. Boulay JL, et al. Among authors: rochlitz c. Br J Cancer. 2002 Sep 9;87(6):630-4. doi: 10.1038/sj.bjc.6600511. Br J Cancer. 2002. PMID: 12237773 Free PMC article.

3

DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer.

Mild G, Bachmann F, Boulay JL, Glatz K, Laffer U, Lowy A, Metzger U, Reuter J, Terracciano L, Herrmann R, Rochlitz C. Mild G, et al. Among authors: rochlitz c. Int J Cancer. 2002 Nov 20;102(3):254-7. doi: 10.1002/ijc.10711. Int J Cancer. 2002. PMID: 12397645

4

SMAD7 is a prognostic marker in patients with colorectal cancer.

Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C. Boulay JL, et al. Among authors: rochlitz c. Int J Cancer. 2003 Apr 20;104(4):446-9. doi: 10.1002/ijc.10908. Int J Cancer. 2003. PMID: 12584741

5

Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey.

Güth U, Singer G, Schötzau A, Langer I, Dieterich H, Rochlitz C, Herberich L, Holzgreve W, Wight E. Güth U, et al. Among authors: rochlitz c. Ann Oncol. 2005 Oct;16(10):1618-23. doi: 10.1093/annonc/mdi319. Epub 2005 Jul 20. Ann Oncol. 2005. PMID: 16033873 Free article. Review.

6

Correlation and significance of histopathological and clinical features in breast cancer with skin involvement (T4b).

Güth U, Wight E, Schötzau A, Langer I, Dieterich H, Rochlitz C, Herberich L, Holzgreve W, Mihatsch MJ, Singer G. Güth U, et al. Among authors: rochlitz c. Hum Pathol. 2006 Mar;37(3):264-71. doi: 10.1016/j.humpath.2005.11.009. Hum Pathol. 2006. PMID: 16613321

7

A new approach in breast cancer with non-inflammatory skin involvement.

Güth U, Wight E, Schötzau A, Langer I, Dieterich H, Rochlitz C, Herberich L, Holzgreve W, Singer G. Güth U, et al. Among authors: rochlitz c. Acta Oncol. 2006;45(5):576-83. doi: 10.1080/02841860600602953. Acta Oncol. 2006. PMID: 16864172

8

Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features.

Gueth U, Wight E, Schoetzau A, Langer I, Dieterich H, Rochlitz C, Herberich L, Holzgreve W, Singer G. Gueth U, et al. Among authors: rochlitz c. J Surg Oncol. 2007 Mar 15;95(4):291-7. doi: 10.1002/jso.20660. J Surg Oncol. 2007. PMID: 17326124

9

Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision.

Güth U, Huang DJ, Dirnhofer S, Rochlitz C, Wight E. Güth U, et al. Among authors: rochlitz c. Cancer J. 2009 Jan-Feb;15(1):81-6. doi: 10.1097/PPO.0b013e31818d8509. Cancer J. 2009. PMID: 19197181

10

[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial.

Iten F, Muller B, Schindler C, Rasch H, Rochlitz C, Oertli D, Maecke HR, Muller-Brand J, Walter MA. Iten F, et al. Among authors: rochlitz c. Cancer. 2009 May 15;115(10):2052-62. doi: 10.1002/cncr.24272. Cancer. 2009. PMID: 19280592 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters